RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

First human test of new drug for tough blood cancers halted early

Disease control Terminated

This early-stage study tested a new drug called NC525 in adults with advanced blood cancers that had returned or stopped responding to standard treatments. The main goal was to check the drug's safety and side effects in 28 participants. The study was terminated early, and while …

Matched conditions: RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control

Last updated Mar 02, 2026 15:26 UTC

RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new RELAPSED OR REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

First human test of new drug for tough blood cancers halted early